Oorsprong van het eerstegraads netwerk van Odisho Israel
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Specific Biologics, Inc.
Specific Biologics, Inc. Miscellaneous Commercial ServicesCommercial Services Specific Biologics, Inc. is a biotechnology company that focuses on developing gene editing technologies to treat diseases through precision gene editing. The company is based in Toronto, Canada. The Canadian company's two-site dualase™ platform gene editors cut DNA in a way that optimally exploits the cells naturally occurring DNA repair pathways, enabling two gene editing outcomes, precise DNA deletions to disrupt genes or increased repair to correct genes. Specific also develops lipid nanoparticles to deliver the gene editor to target cells and is developing a pipeline of dualase™-based therapeutics in areas of high unmet medical need. The company was founded in 2017. The CEO is Brent Stead.
7
| Holding Company | Miscellaneous Commercial Services | 7 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Odisho Israel via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
ARROWHEAD PHARMACEUTICALS, INC. | Biotechnology | Corporate Officer/Principal | |
N-VIRO INTERNATIONAL CORPORATION | Industrial Specialties | Corporate Officer/Principal | |
Cardiac Dimensions, Inc.
Cardiac Dimensions, Inc. Medical SpecialtiesHealth Technology Cardiac Dimensions, Inc. develops novel interventional tools for the treatment of heart failure and the related condition of mitral valve regurgitation. It offers the CARILLON Mitral Contour System, a proprietary and implantable device designed to be positioned in the coronary sinus vein using cardiac catheterization techniques. The firm also offers patient enrollment, clinical testing, and medical consulting services. The company was founded by James W. Fitzsimmons and Scott Jordan Wolf in 2001 and is headquartered in Kirkland, WA. | Medical Specialties | Director/Board Member | |
PRECISION BIOSCIENCES, INC. | Biotechnology | Human Resources Officer | |
CARIBOU BIOSCIENCES, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Lumira Capital Investment Management, Inc.
Lumira Capital Investment Management, Inc. Investment ManagersFinance Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto. | Investment Managers | Private Equity Investor Private Equity Analyst | |
The Johns Hopkins University | College/University | Doctorate Degree | |
University of California, Berkeley | College/University | Undergraduate Degree | |
Resonant Medical, Inc.
Resonant Medical, Inc. Medical SpecialtiesHealth Technology Resonant Medical Inc. develops, manufactures and distributes 3D ultrasound image-guided adaptive radiotherapy products. The company was founded by Fred Francis, Tony Falco and Luc Sirois and is headquartered in Montréal, CA. | Medical Specialties | Director/Board Member | |
U-Systems, Inc.
U-Systems, Inc. Medical SpecialtiesHealth Technology U-Systems, Inc. designs, develops, manufactures and markets ultrasound systems. The company was founded in 1997 and is headquartered in Schenectady, NY. | Medical Specialties | Director/Board Member | |
The State University of New York | College/University | Undergraduate Degree | |
University of Sherbrooke | College/University | Doctorate Degree | |
École des Hautes Études Commerciales de Paris | College/University | Masters Business Admin | |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Pharmaceuticals: Major | Corporate Officer/Principal | |
Réseau Capital
Réseau Capital Miscellaneous Commercial ServicesCommercial Services Réseau Capital operates as a venture capital and private equity association. It promotes private equity industry in Quebec through training, information and promotion, networking, and representation. The company was founded by Jean-Pierre Chartrand in 1989 and is headquartered in Montréal, Canada. | Miscellaneous Commercial Services | Director/Board Member | |
Tata Institute of Fundamental Research
Tata Institute of Fundamental Research Other Consumer ServicesConsumer Services Tata Institute of Fundamental Research owns and operates as a school. It offers computer center, information systems development, central workshop, medical, and technical services. The company was founded by Homi Jehangir Bhabha on June 1, 1945 and is headquartered in Mumbai, India. | College/University | Doctorate Degree | |
IMV INC. | Biotechnology | Director/Board Member | |
The University of Miami Leonard M. Miller School of Medicine | College/University | Doctorate Degree | |
CRISPR THERAPEUTICS AG | Biotechnology | Director/Board Member | |
Gladius Pharmaceuticals, Inc.
Gladius Pharmaceuticals, Inc. BiotechnologyHealth Technology Gladius Pharmaceuticals, Inc. operates as a biotechnology company. It develops novel drugs to treat multi-drug-resistant bacterial infections. The company was founded by Larry D. Sutton and is headquartered in Montréal, Quebec. | Biotechnology | Director/Board Member | |
Gladius Pharmaceuticals Corp.
Gladius Pharmaceuticals Corp. BiotechnologyHealth Technology Gladius Pharmaceuticals Corp. operates as a biotechnology firm. The company is headquartered in Wilmington, DE. | Biotechnology | Director/Board Member | |
Xylocor Therapeutics, Inc.
Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Opsens Medical
Opsens Medical Electrical ProductsProducer Manufacturing Part of Opsens, Inc., Opsens Medical is a Canadian company focused on improving cardiovascular disease diagnosis and treatment. The company is based in Quebec, Canada. Established in 2003, the company believes in the power of innovative technologies to find solutions to challenges and unmet needs in various markets. Opsens Medical capitalizes on its expertise in coronary physiology to extend its activities to the fast-growing sector of structural cardiology. | Electrical Products | Director/Board Member | |
VOR BIOPHARMA INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Kisoji Biotechnology, Inc.
Kisoji Biotechnology, Inc. BiotechnologyHealth Technology Kisoji Biotechnology, Inc. operates as a biotechnology company which develops cancer therapeutics through antibodies and stem cells. The company was founded by David S. Young and is headquartered in Montreal, Canada. | Biotechnology | Director/Board Member | |
OsteoqQC, Inc.
OsteoqQC, Inc. BiotechnologyHealth Technology OsteoqQC, Inc. develops drugs for the treatment of bone-related diseases. The company was founded by Debra Ellies and is headquartered in Montreal, Canada. | Biotechnology | Director/Board Member | |
SANA BIOTECHNOLOGY, INC. | Biotechnology | Corporate Officer/Principal | |
Transposon Therapeutics, Inc.
Transposon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Transposon Therapeutics, Inc. provides pharmaceutical products. The company is headquartered in Westport, CT. | Pharmaceuticals: Major | Director/Board Member | |
Inceptor Bio LLC
Inceptor Bio LLC BiotechnologyHealth Technology Inceptor Bio LLC operates as a biotechnology industry company. The company is headquartered in Raleigh, NC. | Biotechnology | President | |
Congruence Therapeutics, Inc.
Congruence Therapeutics, Inc. BiotechnologyHealth Technology Congruence Therapeutics, Inc. operates as a Canadian biotechnology company. The company is based in Westmount, Canada. Congruence Therapeutics was founded in 2021 by Clarissa Desjardins, who has been the CEO since 2021. | Biotechnology | Director/Board Member | |
LAVA MEDTECH ACQUISITION CORP. | Financial Conglomerates | Corporate Officer/Principal |
Statistieken
Internationaal
Verenigde Staten | 19 |
Canada | 13 |
Frankrijk | 2 |
India | 2 |
Zwitserland | 2 |
Sectoraal
Health Technology | 22 |
Consumer Services | 8 |
Finance | 3 |
Process Industries | 2 |
Commercial Services | 2 |
Operationeel
Director/Board Member | 21 |
Corporate Officer/Principal | 9 |
Doctorate Degree | 4 |
Undergraduate Degree | 2 |
Consultant / Advisor | 2 |
Sterkste connecties
Insiders | |
---|---|
Daniel Hetu | 21 |
Michael Nicholson | 6 |
Steven Kanner | 5 |
Tirtha Chakraborty | 5 |
Nikhil Thatte | 3 |
Brent Stead | 1 |
Frederic Auger | 1 |
- Beurs
- Insiders
- Odisho Israel
- Bedrijfsconnecties